AGL Company Profile and Key Details

AGL has shown mixed momentum, losing -0.98% over the past week and 1.75% over the past quarter, though year-to-date performance is up 41.82%. Short-term trend indicators are bullishly aligned (SMA20 8.49%, SMA50 -17.03%, SMA200 -52.96%). The stock’s 14-day RSI is 50.76 (neutral), while the ATR of 0.07 points to tighter daily ranges. The stock remains hovering near 52-week lows, trading -90.26% below its high and over 75.47% above its low. Average 10-day trading volume of 442.88 thousand shares is slightly above the 3-month average of 327.63 thousand, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Agilon Health, Inc. generated EPS of -$0.78 over the past year. Five-year average earnings growth is 3.29%. Wall Street analysts project EPS growth of 50.4% annually over the next five years. The latest quarter delivered EPS of -$0.27. The next quarter is forecast at $0.04. Next year's EPS is expected at $128.08. Analyst sentiment is neutral. Analyst rating data shows there are 3 Strong Buy ratings, 2 Buy ratings, 6 Hold ratings, 0 Sell rating and 3 Strong Sell ratings. Price targets range from $13.00 to $0.85. The high target offers -53.39% upside. The low target suggests -96.95% downside. The mean target is $2.17. This offers -92.22% upside. Agilon Health, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 04, 2025, missed forecasts by 50.0%. The prior quarter beat by 127.27%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in August 06, 2024.

Agilon Health, Inc. (NYSE:AGL) closed at $27.89 USD, losing -$0.01 (-0.04%) from the previous close of $27.90. The stock is currently mid-range between its 52-week high and low $7.48 and $119.50. With a market capitalization of about $463.14 million, Agilon Health, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.33). Key stats such as the average daily volume over the past year has been around 323.56 thousand shares, trading with heavier-than-usual volume. Headquartered in Austin, TX, Agilon Health, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Ronald Allan Williams, the company employs approximately 1,076 people and listed since April 15, 2021. agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States.

Agilon Health, Inc. has 16.61 million shares outstanding. The public float is 10.72 million shares, elevated short interest at 13.13% of float. This equals 1.36 million shares. The short ratio is 7.0 days. Institutional investors hold 94.69% of the float. Insiders own 2.08%. CD&R Vector Holdings, L.P. holds 194.61 million shares, CD&R Investment Associates IX, Ltd. has 100.00 million shares and Shaker Benjamin has 1.37 million shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Agilon Health, Inc. trades at a P/E ratio of -1.1, slightly below the S&P 500 average, with a price-to-sales ratio of 0.07 and a price-to-book ratio of 3.38 trading at moderately above to book value. The P/FCF stands at -3.06, also below market averages.

Agilon Health, Inc. (NYSE:AGL) shares are up 41.82% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Agilon Health, Inc. trading at a premium to the broader market with a P/E of -1.1. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $14.72, suggesting -47.22% downside. Our AI forecast model points to short-term strength (11.44% over two weeks), a medium-term rise (15.81% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Agilon Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 11.44%, with price expected at $31.08 by May 12, 2026, within a range of $24.86 to $37.25 3-Month Outlook: Projected rise of 15.81%, reaching $32.30 by July 27, 2026, with a range of $25.61 to $35.08. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by April 28, 2027, within a range of $0.00 to $0.00.